170 related articles for article (PubMed ID: 21350220)
1. The science and art of prostate cancer screening.
Yao SL; Lu-Yao GL
J Natl Cancer Inst; 2011 Mar; 103(6):450-1. PubMed ID: 21350220
[No Abstract] [Full Text] [Related]
2. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
Tikkinen KAO; Dahm P; Lytvyn L; Heen AF; Vernooij RWM; Siemieniuk RAC; Wheeler R; Vaughan B; Fobuzi AC; Blanker MH; Junod N; Sommer J; Stirnemann J; Yoshimura M; Auer R; MacDonald H; Guyatt G; Vandvik PO; Agoritsas T
BMJ; 2018 Sep; 362():k3581. PubMed ID: 30185545
[No Abstract] [Full Text] [Related]
3. Prostate specific antigen (PSA) testing as screening for prostate cancer: the current controversy.
Boyle P
Ann Oncol; 1998 Dec; 9(12):1263-4. PubMed ID: 9932152
[No Abstract] [Full Text] [Related]
4. [Prostate cancer screening: no proof of the benefit].
Laplanche A; Hill C
Presse Med; 2009 Oct; 38(10):1393-5. PubMed ID: 19647979
[No Abstract] [Full Text] [Related]
5. Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.
Wever EM; Draisma G; Heijnsdijk EA; Roobol MJ; Boer R; Otto SJ; de Koning HJ
J Natl Cancer Inst; 2010 Mar; 102(5):352-5. PubMed ID: 20142584
[TBL] [Abstract][Full Text] [Related]
6. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
7. Five-year downstream outcomes following prostate-specific antigen screening in older men.
Walter LC; Fung KZ; Kirby KA; Shi Y; Espaldon R; O'Brien S; Freedland SJ; Powell AA; Hoffman RM
JAMA Intern Med; 2013 May; 173(10):866-73. PubMed ID: 23588999
[TBL] [Abstract][Full Text] [Related]
8. Efficacy vs effectiveness in prostate-specific antigen screening.
Albertsen PC
J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
[No Abstract] [Full Text] [Related]
9. Risks of PSA screening now better understood.
Peres J
J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
[No Abstract] [Full Text] [Related]
10. Screening for prostate cancer: prostate-specific antigen testing is not effective.
Hitzeman N; Molina M
Am Fam Physician; 2011 Apr; 83(7):802-4. PubMed ID: 21524045
[No Abstract] [Full Text] [Related]
11. Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC).
Bokhorst LP; Zappa M; Carlsson SV; Kwiatkowski M; Denis L; Paez A; Hugosson J; Moss S; Auvinen A; Roobol MJ
BJU Int; 2016 Nov; 118(5):677-680. PubMed ID: 27104278
[TBL] [Abstract][Full Text] [Related]
12. Navigating Prostate Cancer Screening in the Real World of Primary Care: The Mirage and the Quicksand.
Mathew P; Hachem H; Han P
JAMA Oncol; 2018 Apr; 4(4):453-454. PubMed ID: 29470576
[No Abstract] [Full Text] [Related]
13. Simulated screening for prostate cancer: the useful model.
Church TR
J Natl Cancer Inst; 2003 Jun; 95(12):838-9. PubMed ID: 12813160
[No Abstract] [Full Text] [Related]
14. An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.
Vickers AJ; Till C; Tangen CM; Lilja H; Thompson IM
J Natl Cancer Inst; 2011 Mar; 103(6):462-9. PubMed ID: 21350221
[TBL] [Abstract][Full Text] [Related]
15. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.
Draisma G; Etzioni R; Tsodikov A; Mariotto A; Wever E; Gulati R; Feuer E; de Koning H
J Natl Cancer Inst; 2009 Mar; 101(6):374-83. PubMed ID: 19276453
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.
Carlsson S; Vickers AJ; Roobol M; Eastham J; Scardino P; Lilja H; Hugosson J
J Clin Oncol; 2012 Jul; 30(21):2581-4. PubMed ID: 22711853
[No Abstract] [Full Text] [Related]
17. USPSTF finds little evidence to support advising PSA screening in any man.
Slomski A
JAMA; 2011 Dec; 306(23):2549-51. PubMed ID: 22187266
[No Abstract] [Full Text] [Related]
18. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
Belpomme D; Irigaray P
J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
[No Abstract] [Full Text] [Related]
19. [Detection of prostate cancer: yes or no?].
Van Cangh PJ
Bull Mem Acad R Med Belg; 2006; 161(3-4):159-69. PubMed ID: 17172224
[No Abstract] [Full Text] [Related]
20. Prostate-specific antigen screening in prostate cancer: perspectives on the evidence.
Wilt TJ; Scardino PT; Carlsson SV; Basch E
J Natl Cancer Inst; 2014 Mar; 106(3):dju010. PubMed ID: 24594482
[No Abstract] [Full Text] [Related]
[Next] [New Search]
